Clinical Trial Update: Effects of Mesalamine and Amitriptyline on Irritable Bowel Syndrome [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating mesalamine and amitriptyline for diarrhea-predominant irritable bowel syndrome has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diarrhea-predominant Irritable Bowel Syndrome
• Irritable Bowel Syndrome

Drugs mentioned

• Mesalamine (Mesalamine)
• amitriptyline (amitriptyline)

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Diarrhea- Predominant Irritable Bowel Syndrome, Quality of Life | Phase 4 | Status: WITHDRAWN